Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Badanie uszczelnień TRE u pacjentów we wczesnym okresie pooperacyjnym

9 listopada 2026 zaktualizowane przez: Hollister Incorporated

Badanie uszczelnień TRE u wczesnych pacjentów pooperacyjnych

This study will evaluate two Ostomy Seals/Rings in a group of post-operative patients.

Przegląd badań

Status

Rekrutacyjny

Warunki

Interwencja / Leczenie

Typ studiów

Interwencyjne

Zapisy (Szacowany)

107

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Lokalizacje studiów

    • County Durham
      • Stockton-on-Tees, County Durham, Zjednoczone Królestwo, TS19 8PE
        • Rekrutacyjny
        • North Tees University Hospital
        • Kontakt:
    • East Sussex
      • Saint Leonards-on-Sea, East Sussex, Zjednoczone Królestwo, TN37 7RD
        • Rekrutacyjny
        • East Sussex Healthcare NHS Trust: Conquest and Eastbourne Hospitals
        • Kontakt:
    • Kent
      • Ashford, Kent, Zjednoczone Królestwo, TN24 0LZ
        • Rekrutacyjny
        • William Harvey Hospital
        • Kontakt:
      • Margate, Kent, Zjednoczone Królestwo, CT9 4AN
        • Rekrutacyjny
        • Queen Elizabeth The Queen Mother Hospital
        • Kontakt:
    • North Yorkshire
      • Middlesbrough, North Yorkshire, Zjednoczone Królestwo, TS4 3BW
        • Rekrutacyjny
        • South Tees University Hospital
        • Kontakt:
    • Surrey
      • Redhill, Surrey, Zjednoczone Królestwo, RH1 5RH
        • Rekrutacyjny
        • East Surrey Hospital
        • Kontakt:
    • West Midlands
      • Coventry, West Midlands, Zjednoczone Królestwo, CV2 2DX
        • Rekrutacyjny
        • University Hospital Coventry
        • Kontakt:

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat do 85 lat (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  1. At least 18 years of age
  2. Has their ostomy surgery and post-operative care in the United Kingdom (UK)
  3. Has a colostomy, ileostomy, or urostomy and no reversal planned during the study evaluation period
  4. Able to have first study product applied at first pouch change after surgery (or up to 4 days post-op)
  5. Is appropriate to use a barrier seal per the Investigator
  6. Able to provide an informed consent for study participation
  7. Willing to follow protocol procedures, including participating in study visits, as demonstrated by signing the informed consent

Exclusion Criteria:

  1. Is over 85 years of age
  2. Has received chemotherapy or radiation in the past 30 days or reports beginning chemotherapy or radiation during the study.
  3. A score of 1, 2, or 3 for any of the three OCSI Tool PSC-related domains (i.e., peristomal irritant dermatitis, peristomal bleeding, and hyperplasia) at time of enrollment
  4. Has a fistula in the peristomal area at time of enrollment
  5. Has an open draining wound (not including mucocutaneous separation) in the peristomal area at time of enrollment
  6. Has a suspected infection in the peristomal area at time of enrollment
  7. Is pregnant or lactating at time of enrollment (as determined by interview only)
  8. Is unable to speak, read, and understand English.
  9. Is currently participating in another clinical study using ostomy products
  10. Is currently an employee of Hollister Incorporated or any ostomy manufacturer

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Zapobieganie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Uszczelka stomijna

An absorptive ostomy seal

Aktywny komparator: Pierścień stomijny

The Ostomy Ring contains Aloe

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
The Risk of Peristomal Skin Complications (PSCs) as measured using the three PSC-related questions on the Ostomy Complication Severity Index (OCSI)
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

The three PSC-related questions on the Ostomy Complication Severity Index (OCSI) are related to peristomal irritant dermatitis, peristomal bleeding, and hyperplasia. Each of these three items is rated on a scale of 0-3, with 0 indicating absence of the condition, and 3 indicating the condition is severe.

From enrollment to the end of treatment at 9 weeks

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Total Ostomy Complication Severity Index (OCSI) score and six stomal complication (non-PSC) domains of the OCSI and associated severity
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

Each of the OCSI items are scored on a scale of 0-3, with 0 indicating absence of the condition and 3 indicating the condition is severe.

From enrollment to the end of treatment at 9 weeks
Mediation of peristomal skin complications (PSCs) by leakage absorption measured using the leakage item on the Ostomy Complication Severity Index (OCSI)
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

The leakage item on the OCSI has a scale of 0 (no leakage) to 3 (leakage approximately 1-2 times per day)

From enrollment to the end of treatment at 9 weeks
Visible moisture/effluent on peristomal skin under the study seal area (OCSI Supplementary Question)
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

Assessed only if leakage is reported in the OCSI tool (conditional). Responses: Great amount / Slight amount / None (ordinal categorical).

From enrollment to the end of treatment at 9 weeks
Seal absorption of moisture/effluent under the study seal area (OCSI Supplementary Question)
Ramy czasowe: From enrollment to end of treatment at 9 weeks

Participant response to whether the study seal absorbed moisture/effluent from around the stoma/peristomal skin under the seal. Responses: Yes / Somewhat / No, not at all (ordinal categorical).

From enrollment to end of treatment at 9 weeks
Presence of peristomal skin conditions (OCSI Supplementary Question)
Ramy czasowe: From enrollment to end of treatment at 9 weeks

Checklist of skin conditions present: burning, itching, maceration, fungal rash, folliculitis, granuloma, mechanical trauma, product sensitivity/allergy, pyoderma gangrenosum, other, none.

From enrollment to end of treatment at 9 weeks
Peristomal skin burning severity (OCSI Supplementary Question)
Ramy czasowe: From enrollment to end of treatment at 9 weeks

Rated on a numeric scale from 0 (absent) to 10 (worst burning imaginable). Assessed only if burning is reported (conditional logic from Q25). Higher scores indicate worse burning.

From enrollment to end of treatment at 9 weeks
Peristomal skin itching severity (OCSI Supplementary Question)
Ramy czasowe: From enrollment to end of treatment at 9 weeks

Rated on a numeric scale from 0 (absent) to 10 (worst itching imaginable). Assessed only if itching is reported (conditional logic from Q25). Higher scores indicate worse itching.

From enrollment to end of treatment at 9 weeks
Time to resolution of peristomal skin complications (PSCs), assessed by the Ostomy Complication Severity Instrument (OCSI) at visits and adverse event (AE) reports between visits
Ramy czasowe: From first PSC onset to resolution through end of treatment at 9 weeks

Unit of Measure: days

From first PSC onset to resolution through end of treatment at 9 weeks
Time to recurrence of peristomal skin complications (PSCs) after resolution, assessed by the OCSI at visits and AE reports between visits
Ramy czasowe: From PSC resolution to first recurrence through end of treatment at 9 weeks

Unit of Measure: days

From PSC resolution to first recurrence through end of treatment at 9 weeks
Proportion of participants with PSC occurrence, PSC resolution, and PSC recurrence, assessed by the OCSI at visits and AE reports between visits
Ramy czasowe: From enrollment to end of treatment at 9 weeks

Unit of Measure: percent (%)

From enrollment to end of treatment at 9 weeks
Patient satisfaction with the study Seal/Ring assessed using the Study-Specific Patient Satisfaction Questionnaire (Likert scale)
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

Rated on a 5-point Likert scale from 1 (Very Satisfied) to 5 (Very dissatisfied)

From enrollment to the end of treatment at 9 weeks
Clinician Satisfaction with the study Seal/Ring assessed using the Study-Specific Clinician Satisfaction Questionnaire (Likert scale)
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

Rated on a 5-point Likert scale from 1 (Very Satisfied) to 5 (Very dissatisfied)

From enrollment to the end of treatment at 9 weeks
Ability to correctly use the seal/ring with available instructional resources, assessed by the Study-Specific Instructional Resources Question
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

Single study-specific question assessing whether instructional resources (e.g., IFU, online guides) enabled correct use of the seal/ring; responses: Yes / No / Did not use instructional resources. Results will be reported as the proportion of participants in each response category.

From enrollment to the end of treatment at 9 weeks
Seal swelling/expansion incidence, assessed by Study-Specific Swell/Expand Question
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

Participant response comparing seal size at application versus at barrier change. Responses: No, seal did not swell/expand / Yes, seal swelled/expanded.

From enrollment to the end of treatment at 9 weeks
Effectiveness of seal swelling/expansion for secure fit against leakage, assessed by Study-Specific Swell/Expand Question
Ramy czasowe: From enrollment to end of treatment at 9 weeks

Participant response regarding whether swelling/expansion provided a better, more secure fit against leakage. Responses: No, not at all / Yes, somewhat / Yes, definitely (ordinal categorical).

From enrollment to end of treatment at 9 weeks
Perceived moisture-wicking effect, assessed by the Study-Specific Moisture-Wicking Question (3-point scale)
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

Single study-specific question assessing perceived moisture-wicking away from peristomal skin. Responses: No, not at all / Yes, somewhat / Yes, definitely.

From enrollment to the end of treatment at 9 weeks
Clinician agreement with the study Seal/Ring performance assessed using the Study-Specific Clinician Agreement Questionnaire (Likert scale)
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

Rated on a 5-point Likert scale from 1 (Strongly agree) to 5 (Strongly disagree)

From enrollment to the end of treatment at 9 weeks
Quantity of seals/rings, barriers, and accessories used, assessed by Study-Specific Resource Utilization Log
Ramy czasowe: From enrollment to the end of treatment at 9 weeks

Unit of measure: mean/median number used per participant (counts)

From enrollment to the end of treatment at 9 weeks
Wear/use time (longevity) of seals/rings and barriers, assessed by Study-Specific Resource Utilization Log
Ramy czasowe: From enrollment to end of treatment at 9 weeks

Unit of measure: hours or days of wear time per application (time)

From enrollment to end of treatment at 9 weeks
Peristomal skin-related unplanned healthcare visits, assessed by Study-Specific Healthcare Utilization Question
Ramy czasowe: From enrollment to end of treatment at 9 weeks

Unit of measure: number of visits per participant; optionally proportion with ≥1 visit (counts/%)

From enrollment to end of treatment at 9 weeks
Total ostomy seal/ring costs, derived from quantities recorded in the Resource and Healthcare Utilization Logs
Ramy czasowe: From enrollment to end of treatment at 9 weeks

Unit of measure: currency (e.g., dollars)

From enrollment to end of treatment at 9 weeks

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Śledczy

  • Krzesło do nauki: John Whitaker, University Hospital Coventry

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

30 czerwca 2026

Zakończenie podstawowe (Szacowany)

1 marca 2027

Ukończenie studiów (Szacowany)

1 marca 2027

Daty rejestracji na studia

Pierwszy przesłany

25 lutego 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

3 marca 2026

Pierwszy wysłany (Rzeczywisty)

10 marca 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

12 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

9 listopada 2026

Ostatnia weryfikacja

1 lipca 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • 6042-OST

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

produkt wyprodukowany i wyeksportowany z USA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .